Table 1.

Effects of Neutralizing Antibodies on Monocyte Migration Elicited by MCP-1, MIP-1α, C5a, and Lp(a)

No. of Migrated Cellsn
Control 4.8 ± 0.5 
MCP-1 (50 ng/mL) 21.9 ± 1.8* 
+ anti–MCP-1 (10 μg/mL) 6.1 ± 0.2 
MIP-1α (50 ng/mL) 15.3 ± 1.2* 
+ anti–MIP-1α (10 μg/mL) 5.7 ± 0.3 
C5a (1.0 nmol/L) 22.0 ± 0.7* 
+ anti-C5a (80 μg/mL) 5.2 ± 0.7 
Lp(a) (300 μg/mL) 19.7 ± 0.8* 
+ anti–MCP-1 (10 μg/mL) 19.4 ± 0.3 
+ anti–MIP-1α (10 μg/mL) 20.9 ± 1.3 
+ anti-C5a (80 μg/mL) 20.8 ± 0.9 
No. of Migrated Cellsn
Control 4.8 ± 0.5 
MCP-1 (50 ng/mL) 21.9 ± 1.8* 
+ anti–MCP-1 (10 μg/mL) 6.1 ± 0.2 
MIP-1α (50 ng/mL) 15.3 ± 1.2* 
+ anti–MIP-1α (10 μg/mL) 5.7 ± 0.3 
C5a (1.0 nmol/L) 22.0 ± 0.7* 
+ anti-C5a (80 μg/mL) 5.2 ± 0.7 
Lp(a) (300 μg/mL) 19.7 ± 0.8* 
+ anti–MCP-1 (10 μg/mL) 19.4 ± 0.3 
+ anti–MIP-1α (10 μg/mL) 20.9 ± 1.3 
+ anti-C5a (80 μg/mL) 20.8 ± 0.9 

Monocytes were permitted to migrate across polycarbonate membranes with a pore size of 5 μm for 90 minutes. Results represent the mean ± SEM of migrated cells in seven oil-immersion fields.

*

P < .01 versus HBSS control.

P < .01 versus positive control without neutralizing antibodies.

The number of independent experiments is given as n.

Close Modal

or Create an Account

Close Modal
Close Modal